{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:34:11Z","timestamp":1794558851121,"version":"4.9.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-025-00683-x","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T10:27:31Z","timestamp":1739874451000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Detecting the preoperative peripheral blood systemic immune-inflammation index (SII) as a tool for early diagnosis and prognosis of gallbladder cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Feng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoping","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"683_CR1","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1200\/EDBK_160831","volume":"35","author":"JA Bridgewater","year":"2016","unstructured":"Bridgewater JA, Goodman KA, Kalyan A, Mulcahy MF. Biliary Tract Cancer: Epidemiology, Radiotherapy, and Molecular Profiling. Am Soc Clin Oncol Educ Book. 2016;35:e194\u2013203.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"1117","key":"683_CR2","doi-asserted-by":"publisher","first-page":"20200726","DOI":"10.1259\/bjr.20200726","volume":"94","author":"A Ramachandran","year":"2021","unstructured":"Ramachandran A, Srivastava DN, Madhusudhan KS. Gallbladder cancer revisited: the evolving role of a radiologist. Br J Radiol. 2021;94(1117):20200726.","journal-title":"Br J Radiol"},{"issue":"2","key":"683_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.gtc.2010.02.011","volume":"39","author":"GD Eslick","year":"2010","unstructured":"Eslick GD. Epidemiology of gallbladder cancer. Gastroenterol Clin North Am. 2010;39(2):307\u201330. ix.","journal-title":"Gastroenterol Clin North Am"},{"key":"683_CR4","doi-asserted-by":"publisher","first-page":"106234","DOI":"10.1016\/j.ijsu.2022.106234","volume":"98","author":"CF Feo","year":"2022","unstructured":"Feo CF, Ginesu GC, Fancellu A, Perra T, Ninniri C, Deiana G, et al. Current management of incidental gallbladder cancer: a review. Int J Surg. 2022;98:106234.","journal-title":"Int J Surg"},{"issue":"2","key":"683_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S1072-7515(01)01136-X","volume":"194","author":"GD Wagholikar","year":"2002","unstructured":"Wagholikar GD, Behari A, Krishnani N, Kumar A, Sikora SS, Saxena R, et al. Early gallbladder cancer. J Am Coll Surg. 2002;194(2):137\u201341.","journal-title":"J Am Coll Surg"},{"issue":"1","key":"683_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","volume":"8","author":"JC Roa","year":"2022","unstructured":"Roa JC, Garcia P, Kapoor VK, Maithel SK, Javle M, Koshiol J. Gallbladder cancer. Nat Rev Dis Primers. 2022;8(1):69.","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"683_CR7","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s10620-018-5103-7","volume":"63","author":"W Zhang","year":"2018","unstructured":"Zhang W, Hong HJ, Chen YL. Establishment of a Gallbladder Cancer-Specific Survival Model to predict prognosis in non-metastatic Gallbladder Cancer patients after Surgical Resection. Dig Dis Sci. 2018;63(9):2251\u20138.","journal-title":"Dig Dis Sci"},{"issue":"2","key":"683_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.suc.2018.12.008","volume":"99","author":"L Hickman","year":"2019","unstructured":"Hickman L, Contreras C. Gallbladder Cancer: diagnosis, Surgical Management, and adjuvant therapies. Surg Clin North Am. 2019;99(2):337\u201355.","journal-title":"Surg Clin North Am"},{"issue":"6","key":"683_CR9","doi-asserted-by":"publisher","first-page":"e7411","DOI":"10.1590\/1414-431x20187411","volume":"51","author":"L Pang","year":"2018","unstructured":"Pang L, Zhang Y, Wang Y, Kong J. Pathogenesis of gallbladder adenomyomatosis and its relationship with early-stage gallbladder carcinoma: an overview. Braz J Med Biol Res. 2018;51(6):e7411.","journal-title":"Braz J Med Biol Res"},{"issue":"2","key":"683_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/1751-2980.12966","volume":"22","author":"HZ Lin","year":"2021","unstructured":"Lin HZ, Zhang T, Chen MY, Shen JL. Novel biomarkers for the diagnosis and prognosis of gallbladder cancer. J Dig Dis. 2021;22(2):62\u201371.","journal-title":"J Dig Dis"},{"issue":"1","key":"683_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0304-3835(80)90123-8","volume":"11","author":"HK Kotlar","year":"1980","unstructured":"Kotlar HK, Sanner T. Role of circulating antibodies in the humoral leukocyte adherence inhibition response of lung and breast cancer patients. Cancer Lett. 1980;11(1):11\u20139.","journal-title":"Cancer Lett"},{"issue":"5","key":"683_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000226393","volume":"43","author":"Y Berner","year":"1986","unstructured":"Berner Y, Fink A, Shani A, Weisman Z, Eliraz A, Bruderman I, et al. Diagnostic value of the computerized tube leukocyte adherence inhibition (LAI) assay for human colorectal, breast and lung cancers. Oncology. 1986;43(5):327\u201334.","journal-title":"Oncology"},{"issue":"4","key":"683_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00011-019-01215-1","volume":"68","author":"G Szewczyk","year":"2019","unstructured":"Szewczyk G, Maciejewski TM, Szukiewicz D. Current progress in the inflammatory background of angiogenesis in gynecological cancers. Inflamm Res. 2019;68(4):247\u201360.","journal-title":"Inflamm Res"},{"key":"683_CR14","doi-asserted-by":"publisher","first-page":"106624","DOI":"10.1016\/j.intimp.2020.106624","volume":"85","author":"M Zengin","year":"2020","unstructured":"Zengin M, Karahan I. The role of cancer-related inflammation for prediction of poor survival in postmenopausal female patients with stage II\/III colon cancer. Int Immunopharmacol. 2020;85:106624.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"683_CR15","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1080\/07853890.2021.1991591","volume":"53","author":"X Li","year":"2021","unstructured":"Li X, Gu L, Chen Y, Chong Y, Wang X, Guo P, et al. Systemic immune-inflammation index is a promising non-invasive biomarker for predicting the survival of urinary system cancers: a systematic review and meta-analysis. Ann Med. 2021;53(1):1827\u201338.","journal-title":"Ann Med"},{"issue":"1","key":"683_CR16","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1186\/s12885-022-10218-x","volume":"22","author":"T Xu","year":"2022","unstructured":"Xu T, Zhang SM, Wu HM, Wen XM, Qiu DQ, Yang YY, et al. Prognostic significance of prognostic nutritional index and systemic immune-inflammation index in patients after curative breast cancer resection: a retrospective cohort study. BMC Cancer. 2022;22(1):1128.","journal-title":"BMC Cancer"},{"issue":"34","key":"683_CR17","doi-asserted-by":"publisher","first-page":"6261","DOI":"10.3748\/wjg.v23.i34.6261","volume":"23","author":"JH Chen","year":"2017","unstructured":"Chen JH, Zhai ET, Yuan YJ, Wu KM, Xu JB, Peng JJ, et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol. 2017;23(34):6261\u201372.","journal-title":"World J Gastroenterol"},{"issue":"23","key":"683_CR18","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","volume":"20","author":"B Hu","year":"2014","unstructured":"Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212\u201322.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"683_CR19","doi-asserted-by":"publisher","first-page":"e22964","DOI":"10.1002\/jcla.22964","volume":"33","author":"J Liu","year":"2019","unstructured":"Liu J, Li S, Zhang S, Liu Y, Ma L, Zhu J, et al. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab. J Clin Lab Anal. 2019;33(8):e22964.","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"683_CR20","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1007\/s12029-021-00769-w","volume":"53","author":"E Yekeduz","year":"2022","unstructured":"Yekeduz E, Dogan I, Kaya DM, Ozgur I, Utkan G, Vatansever S, et al. Systemic Immune-inflammation index as a prognostic marker of late recurrence in operable gastric Cancer: a dual-center study. J Gastrointest Cancer. 2022;53(4):870\u20139.","journal-title":"J Gastrointest Cancer"},{"issue":"1","key":"683_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.21873\/anticanres.11329","volume":"37","author":"RC Dolscheid-Pommerich","year":"2017","unstructured":"Dolscheid-Pommerich RC, Manekeller S, Walgenbach-Brunagel G, Kalff JC, Hartmann G, Wagner BS, et al. Clinical performance of CEA, CA19-9, CA15-3, CA125 and AFP in Gastrointestinal Cancer using LOCI-based assays. Anticancer Res. 2017;37(1):353\u20139.","journal-title":"Anticancer Res"},{"key":"683_CR22","doi-asserted-by":"publisher","first-page":"4475","DOI":"10.2147\/CMAR.S255480","volume":"12","author":"Z Chen","year":"2020","unstructured":"Chen Z, Liu Z, Zhang Y, Wang P, Gao H. Combination of CA19-9 and the neutrophil-to-lymphocyte ratio for the Differential diagnosis of Gallbladder Carcinoma. Cancer Manag Res. 2020;12:4475\u201382.","journal-title":"Cancer Manag Res"},{"issue":"5","key":"683_CR23","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1159\/000506628","volume":"37","author":"Y Yamamoto","year":"2020","unstructured":"Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Ohgi K, et al. Surgical indication for Advanced Gallbladder Cancer considering the Optimal Preoperative Carbohydrate Antigen 19\u2009\u2013\u20099 cutoff value. Dig Surg. 2020;37(5):390\u2013400.","journal-title":"Dig Surg"},{"issue":"11","key":"683_CR24","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.4240\/wjgs.v14.i11.1272","volume":"14","author":"SR Sinha","year":"2022","unstructured":"Sinha SR, Prakash P, Singh RK, Sinha DK. Assessment of tumor markers CA 19\u2009\u2013\u20099, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer. World J Gastrointest Surg. 2022;14(11):1272\u201384.","journal-title":"World J Gastrointest Surg"},{"key":"683_CR25","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.3332\/ecancer.2024.1660","volume":"18","author":"RN Velasco Jr","year":"2024","unstructured":"Velasco RN Jr., Tan HNC, Juan MDS. Haematologic biomarkers and survival in gallbladder cancer: a systematic review and meta-analysis. Ecancermedicalscience. 2024;18:1660.","journal-title":"Ecancermedicalscience"},{"issue":"2","key":"683_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s12029-021-00596-z","volume":"53","author":"G Rovesti","year":"2022","unstructured":"Rovesti G, Leone F, Brandi G, Fornaro L, Scartozzi M, Niger M, et al. Prognostic role of a New Index tested in European and Korean advanced biliary Tract Cancer patients: the PECS Index. J Gastrointest Cancer. 2022;53(2):289\u201398.","journal-title":"J Gastrointest Cancer"},{"issue":"1","key":"683_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/jso.26470","volume":"124","author":"H Chen","year":"2021","unstructured":"Chen H, Huang Z, Sun B, Wang A, Wang Y, Shi H, et al. The predictive value of systemic immune inflammation index for postoperative survival of gallbladder carcinoma patients. J Surg Oncol. 2021;124(1):59\u201366.","journal-title":"J Surg Oncol"},{"issue":"14","key":"683_CR28","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.3748\/wjg.v20.i14.4085","volume":"20","author":"YF Wang","year":"2014","unstructured":"Wang YF, Feng FL, Zhao XH, Ye ZX, Zeng HP, Li Z, et al. Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer. World J Gastroenterol. 2014;20(14):4085\u201392.","journal-title":"World J Gastroenterol"},{"key":"683_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.puhe.2021.12.002","volume":"203","author":"C Nie","year":"2022","unstructured":"Nie C, Yang T, Liu L, Hong F. Trend analysis and risk of gallbladder cancer mortality in China, 2013\u20132019. Public Health. 2022;203:31\u20135.","journal-title":"Public Health"},{"issue":"2","key":"683_CR30","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s12029-011-9284-y","volume":"43","author":"T Rustagi","year":"2012","unstructured":"Rustagi T, Dasanu CA. Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates. J Gastrointest Cancer. 2012;43(2):137\u201347.","journal-title":"J Gastrointest Cancer"},{"issue":"4","key":"683_CR31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.21037\/cco.2019.08.14","volume":"8","author":"M Javle","year":"2019","unstructured":"Javle M, Zhao H, Abou-Alfa GK. Systemic therapy for gallbladder cancer. Chin Clin Oncol. 2019;8(4):44.","journal-title":"Chin Clin Oncol"},{"issue":"4","key":"683_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.21037\/cco.2019.08.13","volume":"8","author":"MA Schmidt","year":"2019","unstructured":"Schmidt MA, Marcano-Bonilla L, Roberts LR. Gallbladder cancer: epidemiology and genetic risk associations. Chin Clin Oncol. 2019;8(4):31.","journal-title":"Chin Clin Oncol"},{"issue":"12","key":"683_CR33","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.3760\/cma.j.issn.0366-6999.20131734","volume":"127","author":"T Yu","year":"2014","unstructured":"Yu T, Yu H, Cai X. Preoperative prediction of survival in resectable gallbladder cancer by a combined utilization of CA 19\u2009\u2013\u20099 and carcinoembryonic antigen. Chin Med J (Engl). 2014;127(12):2299\u2013303.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"683_CR34","doi-asserted-by":"publisher","first-page":"23554","DOI":"10.1038\/s41598-021-02923-7","volume":"11","author":"R Priya","year":"2021","unstructured":"Priya R, Jain V, Akhtar J, Chauhan G, Sakhuja P, Goyal S, et al. Plasma-derived candidate biomarkers for detection of gallbladder carcinoma. Sci Rep. 2021;11(1):23554.","journal-title":"Sci Rep"},{"issue":"8","key":"683_CR35","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10654-021-00752-6","volume":"36","author":"TH Nost","year":"2021","unstructured":"Nost TH, Alcala K, Urbarova I, Byrne KS, Guida F, Sandanger TM, et al. Systemic inflammation markers and cancer incidence in the UK Biobank. Eur J Epidemiol. 2021;36(8):841\u20138.","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"683_CR36","doi-asserted-by":"publisher","first-page":"428","DOI":"10.5582\/bst.2020.03326","volume":"14","author":"Y Bao","year":"2021","unstructured":"Bao Y, Yang J, Duan Y, Chen Y, Chen W, Sun D. The C-reactive protein to albumin ratio is an excellent prognostic predictor for gallbladder cancer. Biosci Trends. 2021;14(6):428\u201335.","journal-title":"Biosci Trends"},{"issue":"2","key":"683_CR37","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/ijc.34012","volume":"151","author":"T Liu","year":"2022","unstructured":"Liu T, Zhang Q, Song C, Siyin ST, Chen S, Zhang Q, et al. C-reactive protein trajectories and the risk of all cancer types: a prospective cohort study. Int J Cancer. 2022;151(2):297\u2013307.","journal-title":"Int J Cancer"},{"key":"683_CR38","doi-asserted-by":"publisher","first-page":"554521","DOI":"10.3389\/fonc.2020.554521","volume":"10","author":"L Sun","year":"2020","unstructured":"Sun L, Jin Y, Hu W, Zhang M, Jin B, Xu H, et al. The impacts of systemic Immune-inflammation index on clinical outcomes in Gallbladder Carcinoma. Front Oncol. 2020;10:554521.","journal-title":"Front Oncol"},{"issue":"2","key":"683_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5114\/ceh.2019.85166","volume":"5","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Thandra KC, Barsouk A. Epidemiology of gallbladder cancer. Clin Exp Hepatol. 2019;5(2):93\u2013102.","journal-title":"Clin Exp Hepatol"},{"issue":"5","key":"683_CR40","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.4103\/jcrt.jcrt_1754_21","volume":"19","author":"R Mani","year":"2023","unstructured":"Mani R, Gupta A, Gupta S, Goyal B, Mishra R, Tandon A, et al. Expression of ER, PR, and HER-2 Neu and correlation with tumor markers in gall bladder carcinoma. J Cancer Res Ther. 2023;19(5):1279\u201387.","journal-title":"J Cancer Res Ther"},{"issue":"2","key":"683_CR41","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1515\/cclm-2012-0414","volume":"51","author":"G Cartei","year":"2013","unstructured":"Cartei G, Cartei F, Bertin M, Padoan A, Zustovich F, Nicoletto MO, et al. CA125 reference values change in male and postmenopausal female subjects. Clin Chem Lab Med. 2013;51(2):413\u20139.","journal-title":"Clin Chem Lab Med"},{"key":"683_CR42","doi-asserted-by":"publisher","first-page":"737283","DOI":"10.3389\/fonc.2021.737283","volume":"11","author":"S Tian","year":"2021","unstructured":"Tian S, Cao Y, Duan Y, Liu Q, Peng P. Gustave Roussy Immune score as a Novel Prognostic Scoring System for Colorectal Cancer patients: a propensity score matching analysis. Front Oncol. 2021;11:737283.","journal-title":"Front Oncol"},{"issue":"45","key":"683_CR43","doi-asserted-by":"publisher","first-page":"e13156","DOI":"10.1097\/MD.0000000000013156","volume":"97","author":"MY Tao","year":"2018","unstructured":"Tao MY, Wang ZH, Zhang MH, Ma TH, Yang XZ, Wu SN, et al. Prognostic value of the systematic immune-inflammation index among patients with operable colon cancer: a retrospective study. Med (Baltim). 2018;97(45):e13156.","journal-title":"Med (Baltim)"},{"issue":"3","key":"683_CR44","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1245\/s10434-019-08094-0","volume":"27","author":"P Murthy","year":"2020","unstructured":"Murthy P, Zenati MS, Al Abbas AI, Rieser CJ, Bahary N, Lotze MT, et al. Prognostic value of the systemic Immune-inflammation index (SII) after neoadjuvant therapy for patients with resected pancreatic Cancer. Ann Surg Oncol. 2020;27(3):898\u2013906.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"683_CR45","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1097\/IGC.0000000000000804","volume":"26","author":"F Dayyani","year":"2016","unstructured":"Dayyani F, Uhlig S, Colson B, Simon K, Rolny V, Morgenstern D, et al. Diagnostic performance of risk of ovarian malignancy Algorithm Against CA125 and HE4 in connection with ovarian Cancer: a Meta-analysis. Int J Gynecol Cancer. 2016;26(9):1586\u201393.","journal-title":"Int J Gynecol Cancer"},{"key":"683_CR46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1515\/med-2017-0020","volume":"12","author":"J Guo","year":"2017","unstructured":"Guo J, Yu J, Song X, Mi H. Serum CA125, CA199 and CEA combined detection for epithelial ovarian Cancer diagnosis: a Meta-analysis. Open Med (Wars). 2017;12:131\u20137.","journal-title":"Open Med (Wars)"},{"key":"683_CR47","doi-asserted-by":"publisher","first-page":"7131","DOI":"10.2147\/JIR.S345790","volume":"14","author":"H Lei","year":"2021","unstructured":"Lei H, Xu S, Mao X, Chen X, Chen Y, Sun X, et al. Systemic Immune-Inflammatory Index as a predictor of Lymph Node Metastasis in Endometrial Cancer. J Inflamm Res. 2021;14:7131\u201342.","journal-title":"J Inflamm Res"},{"issue":"37","key":"683_CR48","doi-asserted-by":"publisher","first-page":"e35240","DOI":"10.1097\/MD.0000000000035240","volume":"102","author":"L Song","year":"2023","unstructured":"Song L, Qi J, Zhao J, Bai S, Wu Q, Xu R. Diagnostic value of CA125, HE4, and systemic immune-inflammation index in the preoperative investigation of ovarian masses. Med (Baltim). 2023;102(37):e35240.","journal-title":"Med (Baltim)"},{"key":"683_CR49","doi-asserted-by":"publisher","first-page":"1229349","DOI":"10.3389\/fonc.2023.1229349","volume":"13","author":"W Liu","year":"2023","unstructured":"Liu W, Zhang Y, Wang M, Wang M, Yang Q. High systemic immune-inflammation index predicts poor prognosis and response to intravesical BCG treatment in patients with urothelial carcinoma: a systematic review and meta-analysis. Front Oncol. 2023;13:1229349.","journal-title":"Front Oncol"},{"key":"683_CR50","doi-asserted-by":"publisher","first-page":"915599","DOI":"10.3389\/fsurg.2022.915599","volume":"9","author":"R Han","year":"2022","unstructured":"Han R, Tian Z, Jiang Y, Guan G, Wang X, Sun X, et al. Prognostic significance of the systemic immune inflammation index in patients with metastatic and unresectable pancreatic cancer. Front Surg. 2022;9:915599.","journal-title":"Front Surg"},{"issue":"5","key":"683_CR51","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.21037\/jgo-22-716","volume":"13","author":"L Feng","year":"2022","unstructured":"Feng L, Xu R, Lin L, Liao X. Effect of the systemic immune-inflammation index on postoperative complications and the long-term prognosis of patients with colorectal cancer: a retrospective cohort study. J Gastrointest Oncol. 2022;13(5):2333\u20139.","journal-title":"J Gastrointest Oncol"},{"issue":"10","key":"683_CR52","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.21037\/gs-22-459","volume":"11","author":"J Wang","year":"2022","unstructured":"Wang J, Yin S, Chen K. Predictive value of the systemic immune-inflammation index for the efficacy of neoadjuvant chemotherapy and prognosis in patients with stage III ovarian cancer-a retrospective cohort study. Gland Surg. 2022;11(10):1639\u201346.","journal-title":"Gland Surg"},{"issue":"2","key":"683_CR53","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s11605-019-04492-7","volume":"25","author":"D Wang","year":"2021","unstructured":"Wang D, Hu X, Xiao L, Long G, Yao L, Wang Z, et al. Prognostic Nutritional Index and systemic Immune-inflammation index predict the prognosis of patients with HCC. J Gastrointest Surg. 2021;25(2):421\u20137.","journal-title":"J Gastrointest Surg"},{"issue":"4","key":"683_CR54","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1620\/tjem.236.297","volume":"236","author":"X Hong","year":"2015","unstructured":"Hong X, Cui B, Wang M, Yang Z, Wang L, Xu Q. Systemic Immune-inflammation index, based on platelet counts and neutrophil-lymphocyte ratio, is useful for Predicting Prognosis in Small Cell Lung Cancer. Tohoku J Exp Med. 2015;236(4):297\u2013304.","journal-title":"Tohoku J Exp Med"},{"issue":"8","key":"683_CR55","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s00384-020-03659-y","volume":"35","author":"S Yatabe","year":"2020","unstructured":"Yatabe S, Eto K, Haruki K, Shiba H, Kosuge M, Ohkuma M, et al. Correction to: signification of systemic Immune-inflammation index for prediction of prognosis after resecting in patients with colorectal cancer. Int J Colorectal Dis. 2020;35(8):1557.","journal-title":"Int J Colorectal Dis"},{"issue":"1","key":"683_CR56","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/SLA.0000000000002660","volume":"270","author":"MH Aziz","year":"2019","unstructured":"Aziz MH, Sideras K, Aziz NA, Mauff K, Haen R, Roos D, et al. The systemic-immune-inflammation index independently predicts survival and recurrence in Resectable Pancreatic Cancer and its Prognostic Value depends on bilirubin levels: a retrospective Multicenter Cohort Study. Ann Surg. 2019;270(1):139\u201346.","journal-title":"Ann Surg"},{"issue":"1","key":"683_CR57","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/1078155220913106","volume":"27","author":"S Yucel","year":"2021","unstructured":"Yucel S, Bilgin B. The prognostic values of systemic immune-inflammation index and derived neutrophil-lymphocyte ratio in EGFR-mutant advanced non-small cell lung cancer. J Oncol Pharm Pract. 2021;27(1):71\u20137.","journal-title":"J Oncol Pharm Pract"},{"issue":"10391","key":"683_CR58","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","volume":"401","author":"RK Kelley","year":"2023","unstructured":"Kelley RK, Ueno M, Yoo C, Finn RS, Furuse J, Ren Z, et al. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023;401(10391):1853\u201365.","journal-title":"Lancet"},{"issue":"3","key":"683_CR59","doi-asserted-by":"publisher","first-page":"e556","DOI":"10.1097\/SLA.0000000000005784","volume":"278","author":"SS Irani","year":"2023","unstructured":"Irani SS, Sharma NR, Storm AC, Shah RJ, Chahal P, Willingham FF, et al. Endoscopic ultrasound-guided transluminal gallbladder drainage in patients with Acute Cholecystitis: a prospective Multicenter Trial. Ann Surg. 2023;278(3):e556\u201362.","journal-title":"Ann Surg"},{"issue":"4","key":"683_CR60","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1158\/1055-9965.EPI-16-0796","volume":"26","author":"PT Campbell","year":"2017","unstructured":"Campbell PT, Newton CC, Kitahara CM, Patel AV, Hartge P, Koshiol J, et al. Body size indicators and risk of Gallbladder Cancer: pooled analysis of individual-Level Data from 19 prospective cohort studies. Cancer Epidemiol Biomarkers Prev. 2017;26(4):597\u2013606.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"683_CR61","doi-asserted-by":"publisher","first-page":"e89368","DOI":"10.1371\/journal.pone.0089368","volume":"9","author":"W Borena","year":"2014","unstructured":"Borena W, Edlinger M, Bjorge T, Haggstrom C, Lindkvist B, Nagel G, et al. A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study. PLoS ONE. 2014;9(2):e89368.","journal-title":"PLoS ONE"},{"key":"683_CR62","doi-asserted-by":"publisher","first-page":"692647","DOI":"10.3389\/fonc.2021.692647","volume":"11","author":"L Li","year":"2021","unstructured":"Li L, Ren T, Liu K, Li ML, Geng YJ, Yang Y, et al. Development and validation of a Prognostic Nomogram based on the systemic Immune-inflammation index for Resectable Gallbladder Cancer to Predict Survival and Chemotherapy Benefit. Front Oncol. 2021;11:692647.","journal-title":"Front Oncol"},{"key":"683_CR63","doi-asserted-by":"publisher","first-page":"1116224","DOI":"10.3389\/fimmu.2023.1116224","volume":"14","author":"X Di","year":"2023","unstructured":"Di X, Liu S, Xiang L, Jin X. Association between the systemic immune-inflammation index and kidney stone: a cross-sectional study of NHANES 2007\u20132018. Front Immunol. 2023;14:1116224.","journal-title":"Front Immunol"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-025-00683-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-025-00683-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-025-00683-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T10:27:34Z","timestamp":1739874454000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-025-00683-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["683"],"URL":"https:\/\/doi.org\/10.1186\/s12865-025-00683-x","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"27 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed and ratified by the Academic Ethics Committee of The First Hospital of Shanxi Medical University and complied with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was waived due to the retrospective nature of the analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}